AI-enabled Precision Medicine
Bringing the power of data and artificial intelligence to healthcare
LEADING DIAGNOSTIC COMPANY PROVIDING
PREDICTIVE
PROGNOSTIC
TREATMENTS
PERSONALISED
OUR PRODUCTS
xT: SOLID TUMOR
- Solid Tumor and hematologic malignancies
- 648 Genes analyzed
- Incidental Germline (Tumor Normal Match)
- DNA + RNA transcriptome validated fusion detection
- Immune Biomarkers- TMB, MSI
xE: WHOLE EXOME
- 19000+ Genes analyzed
- Solid tumor and hematologic malignancies
- Incidental Germline (Tumor Normal Match)
- DNA + RNA transcriptome validated fusion detection
- Immune Biomarkers- TMB, MSI
xF: LIQUID BIOPSY
- Solid Tumor only
- 105 genes analyzed
- Immune biomarkers- MSI high
- Auto-conversion options from xT in event of tissue NGS failure/QNS
For any medical enquiry,
Contact us at +91 9591736262 or
Email us at info@sayretherapeutics.com
For more information https://www.tempus.com/